CN115671551A - Control method and device of intermediate frequency pulse therapeutic apparatus and therapeutic apparatus - Google Patents
Control method and device of intermediate frequency pulse therapeutic apparatus and therapeutic apparatus Download PDFInfo
- Publication number
- CN115671551A CN115671551A CN202310001082.0A CN202310001082A CN115671551A CN 115671551 A CN115671551 A CN 115671551A CN 202310001082 A CN202310001082 A CN 202310001082A CN 115671551 A CN115671551 A CN 115671551A
- Authority
- CN
- China
- Prior art keywords
- parameters
- prescription
- waveform
- user
- treatment time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P90/00—Enabling technologies with a potential contribution to greenhouse gas [GHG] emissions mitigation
- Y02P90/02—Total factory control, e.g. smart factories, flexible manufacturing systems [FMS] or integrated manufacturing systems [IMS]
Landscapes
- Electrotherapy Devices (AREA)
Abstract
The embodiment of the disclosure discloses a control method and device of an intermediate frequency pulse therapeutic apparatus and a therapeutic apparatus. The control method of the intermediate frequency pulse therapeutic apparatus comprises the following steps: responding to a user setting instruction, analyzing prescription parameters set by the user to obtain an analysis result; calculating a waveform parameter based on the analysis result; judging whether the parameters meet the set requirements or not based on the obtained waveform parameters; if the treatment time is in accordance with the set requirement, judging whether the set treatment time is reached; when the set treatment time is up, judging whether all the prescriptions set by the user are executed; if the user sets that the prescription has been completely executed, the method is ended. The prescription set by the user is analyzed, and then the waveform parameters are calculated according to the analysis result, so that the adaptive waveform is used for treatment, and various adaptive waveforms can be generated according to the setting in one treatment mode, so that the aim of improving the treatment effect is fulfilled.
Description
Technical Field
The disclosure relates to the field of health equipment, in particular to a control method and device of an intermediate frequency pulse therapeutic apparatus and the therapeutic apparatus.
Background
The method of treating diseases by applying pulse current with frequency of 1 KHZ-100 KHZ is called medium frequency electrotherapy. Medium frequency electrotherapy has a long history as a physical therapy. In recent years, intermediate frequency therapeutic apparatuses have been widely used in departments such as pain department, rehabilitation and physiotherapy department, neurology department, and gynecology department of various hospitals, and institutions such as experience stores, clinics, nursing homes, rehabilitation centers, and community hospitals.
The medium frequency therapeutic instrument simulates the traditional Chinese medicine acupuncture and moxibustion theory, integrates various functions of electrotherapy, magnetotherapy, thermotherapy and the like, and uses pulse current controlled by a microcomputer to act on the skin of acupuncture points of a human body to dredge blood vessels and nerves so as to achieve the effect of smooth transmission. The medium frequency therapeutic apparatus acts on human body to produce analgesic effect, relieve muscle spasm, improve local blood circulation, promote the absorption of inflammatory substances, has obvious functions of diminishing inflammation and detumescence, and also has the effects of softening scar and loosening adhesion. In the process of implementing the embodiment of the present disclosure, the inventor finds that the prior art has the problem that the waveform is single, and only one waveform is used for one therapy, so that the treatment effect is poor.
Disclosure of Invention
In view of this, the disclosed embodiments provide a method and a device for controlling an if pulse therapeutic apparatus, and a therapeutic apparatus, which at least partially solve the problem of single waveform in the prior art.
In a first aspect, an embodiment of the present disclosure provides a method for controlling an intermediate frequency pulse therapeutic apparatus, including:
responding to a user setting instruction, and analyzing prescription parameters set by a user to obtain an analysis result;
calculating waveform parameters based on the analysis result;
judging whether the parameters meet the set requirements or not based on the obtained waveform parameters;
if the treatment time meets the set requirement, judging whether the set treatment time is reached;
when the set treatment time is up, judging whether all the prescriptions set by the user are executed;
if the user sets that the prescription has been completely executed, the method is ended.
Optionally, the prescription parameters set by the user include treatment channels, prescription number and prescription.
Optionally, the parsing result includes:
a mid-frequency, a prescription waveform, a low-frequency, and a low-frequency amplitude modulation.
Optionally, the calculating the waveform parameter includes:
generating random parameters based on the analysis result;
checking the random parameter;
and carrying out superposition secondary modulation on the random parameters passing the verification to obtain waveform parameters.
Optionally, after the step of determining whether the set treatment time is reached, the method further includes:
if the set treatment time is not reached, judging whether to replace the waveform parameters;
if the waveform parameters need to be updated, the waveform parameters are calculated from the new waveform parameters.
In a second aspect, an embodiment of the present disclosure further provides a control device for an intermediate frequency pulse therapeutic apparatus, including:
the analysis module is used for responding to the user setting instruction and analyzing the prescription parameters set by the user to obtain an analysis result;
the calculation module is used for calculating the waveform parameters based on the analysis result;
the parameter judging module is used for judging whether the parameters meet the set requirements or not based on the obtained waveform parameters;
the time judging module is used for judging whether the set treatment time is reached or not if the set treatment time is met;
the prescription judging module is used for judging whether all prescriptions set by the user are executed when the set treatment time is reached;
and the ending module is used for ending if the prescription set by the user is completely executed.
Optionally, the prescription parameters set by the user include treatment channels, prescription number and prescription.
Optionally, the parsing result includes:
medium frequency, prescription waveform, low frequency, and low frequency amplitude.
Optionally, the calculating the waveform parameter includes:
generating random parameters based on the analysis result;
checking the random parameter;
and carrying out superposition secondary modulation on the random parameters passing the verification to obtain waveform parameters.
In a third aspect, an embodiment of the present disclosure further provides an intermediate frequency pulse therapeutic apparatus, including: the control method according to any one of the first aspect.
According to the control method and device for the intermediate frequency pulse therapeutic apparatus and the therapeutic apparatus, the prescription set by the user is analyzed, and then the waveform parameters are calculated according to the analysis result, so that the appropriate waveforms are used for treatment, and various appropriate waveforms can be generated according to the setting in one treatment mode, so that the purpose of improving the treatment effect is achieved.
The foregoing is a summary of the present disclosure, and for the purposes of promoting a clear understanding of the technical means of the present disclosure, the present disclosure may be embodied in other specific forms without departing from the spirit or essential attributes thereof.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present disclosure, the drawings needed to be used in the embodiments will be briefly described below, and it is apparent that the drawings in the following description are only some embodiments of the present disclosure, and it is obvious for those skilled in the art that other drawings can be obtained according to the drawings without creative efforts.
Fig. 1 is a flowchart of a control method of an intermediate frequency pulse therapeutic apparatus according to an embodiment of the present disclosure;
fig. 2 is an electronic circuit diagram of a master control circuit provided in an embodiment of the disclosure;
fig. 3 is an electronic circuit diagram of a serial communication circuit provided in an embodiment of the present disclosure;
FIG. 4 is an electronic circuit diagram of an FPGA circuit provided by an embodiment of the present disclosure;
fig. 5 is an electronic circuit diagram of a digital-to-analog conversion circuit provided in an embodiment of the present disclosure;
fig. 6 is an electronic circuit diagram of a 5V power supply circuit provided by an embodiment of the disclosure;
FIG. 7 is an electronic circuit diagram of a reference power circuit provided by an embodiment of the present disclosure;
fig. 8 is an electronic circuit diagram of a 3.3V power supply circuit provided by an embodiment of the disclosure;
fig. 9 is an electronic circuit diagram of a first interface circuit provided by an embodiment of the disclosure;
fig. 10 is an electronic circuit diagram of a driving circuit provided by an embodiment of the present disclosure;
FIG. 11 is an electrical schematic diagram of a second interface circuit provided by an embodiment of the present disclosure;
fig. 12 is an electronic circuit diagram of a level shift circuit provided in an embodiment of the present disclosure;
fig. 13 is an electronic circuit diagram of a communication circuit provided by an embodiment of the present disclosure;
fig. 14 is an electronic circuit diagram of a board address selection circuit provided in the embodiment of the present disclosure;
fig. 15 is an electronic circuit diagram of a waveform output circuit provided by an embodiment of the present disclosure;
fig. 16 is an electronic circuit diagram of a single-channel waveform selection circuit provided by an embodiment of the present disclosure;
fig. 17 is an electronic circuit diagram of a power amplification circuit provided by an embodiment of the present disclosure;
fig. 18 is an electronic circuit diagram of an analog-to-digital conversion circuit provided by an embodiment of the present disclosure;
fig. 19 is an electronic circuit diagram of a signal acquisition circuit provided in an embodiment of the present disclosure.
Detailed Description
The embodiments of the present disclosure are described in detail below with reference to the accompanying drawings.
It is to be understood that the embodiments of the present disclosure are described below by specific examples, and other advantages and effects of the present disclosure will be readily apparent to those skilled in the art from the disclosure herein. It is to be understood that the described embodiments are merely illustrative of some, and not restrictive, of the embodiments of the disclosure. The disclosure may be carried into practice or applied to various other specific embodiments, and various modifications and changes may be made in the details within the description and the drawings without departing from the spirit of the disclosure. It is to be noted that the features in the following embodiments and examples may be combined with each other without conflict. All other embodiments, which can be derived by a person skilled in the art from the embodiments disclosed herein without making any creative effort, shall fall within the protection scope of the present disclosure.
It is noted that various aspects of the embodiments are described below within the scope of the appended claims. It should be apparent that the aspects described herein may be embodied in a wide variety of forms and that any specific structure and/or function described herein is merely illustrative. Based on the disclosure, one skilled in the art should appreciate that one aspect described herein may be implemented independently of any other aspects and that two or more of these aspects may be combined in various ways. For example, an apparatus may be implemented and/or a method practiced using any number of the aspects set forth herein. In addition, such an apparatus may be implemented and/or such a method may be practiced using other structure and/or functionality in addition to or other than one or more of the aspects set forth herein.
It should be further noted that the drawings provided in the following embodiments are only for illustrating the basic idea of the present disclosure, and the drawings only show the components related to the present disclosure rather than being drawn according to the number, shape and size of the components in actual implementation, and the type, amount and proportion of each component in actual implementation may be changed freely, and the layout of the components may be more complicated.
In addition, in the following description, specific details are provided to facilitate a thorough understanding of the examples. However, it will be understood by those skilled in the art that the aspects may be practiced without these specific details.
For easy understanding, as shown in fig. 1, the present embodiment discloses a method for controlling an intermediate frequency pulse therapeutic apparatus, including:
responding to a user setting instruction, and analyzing prescription parameters set by a user to obtain an analysis result;
calculating a waveform parameter based on the analysis result;
the waveform parameters include: waveform, mid-frequency, low-frequency, and low-frequency amplitude, the parameter ranges for different recipes are different, in one example: the formula 01-A has sine wave parameters, medium frequency of 1-10KHz, low frequency of 150-200Hz, and low frequency amplitude of 0-100%.
Judging whether the parameters meet the set requirements or not based on the obtained waveform parameters;
during treatment, the program randomly generates a group of medium frequency, low frequency and low frequency modulation amplitude at intervals, and the data range of the medium frequency, the low frequency and the low frequency modulation amplitude does not exceed the prescribed limit value.
If the treatment time meets the set requirement, judging whether the set treatment time is reached;
when the set treatment time is up, judging whether all prescriptions set by the user are executed;
if the user sets that the prescription has been completely executed, the method is ended.
Optionally, the prescription parameters set by the user include treatment channels, prescription number and prescription.
Optionally, the parsing result includes:
medium frequency, prescription waveform, low frequency, and low frequency amplitude. The low frequency comprises a low frequency range and the low frequency amplitude comprises a low frequency amplitude.
Optionally, the calculating the waveform parameter includes:
generating random parameters based on the analysis result;
checking the random parameter;
and carrying out superposition secondary modulation on the random parameters passing the verification to obtain waveform parameters.
Optionally, after the step of determining whether the set treatment time is reached, the method further includes:
if the set treatment time is not reached, judging whether to replace the waveform parameters;
if the waveform parameters need to be updated, the waveform parameters are calculated from the new waveform parameters.
The prescription of this embodiment is composed of 3 digits and characters, the 1 st and 2 nd digits are numbers, the 3 rd digit is letters, and the 2 nd and 3 rd digits are separated by "-". The first two bits of data are 15 in total, the third letter is 6 in total from A to F, and the total number of prescriptions is 15 x 6 and 90 in total (for example: 01-A). The 1,2 nd bit is a number representing the combination of the carrier frequency (intermediate frequency) and the low frequency as shown in table 1.
TABLE 1 combination of carrier frequency and low frequency
(3) Prescription selection:
1. various pains, inhibition of sympathetic nerves (low frequency 150 Hz-200 Hz): 01-A to 01-F.
2. Various pains, inhibition of sympathetic nerves (low frequency 100 Hz-150 Hz): 02-A to 02-F.
3. Various pains, inhibition of sympathetic nerves (low frequency 50 Hz-100 Hz): 03-A to 03-F.
4. Exciting motor nerves, causing muscle contraction (low frequency 25Hz to 50 Hz): 04-A to 04-F.
5. Exciting vagus nerve, dilating local blood vessel, and making normal skeletal muscle incompletely contract (low frequency 20 Hz-40 Hz): 05-A to 05-F.
6. The muscles of absence innervation are contracted, and sympathetic nerves are excited (the triangular wave is optimal) (the low-frequency is 1 Hz-10 Hz): 06-A to 06-F.
7. Antiphlogistic, spasmolytic and analgesic (low frequency 50 Hz-100 Hz): 07-A to 07-F.
8. Inhibit sympathetic nerve, promote focus detumescence and dissipate (low frequency 90 Hz-100 Hz): 08-A to 08-F.
9. Vertebral artery type cervical spondylosis (low frequency 90Hz to 100 Hz): 09-A to 09-F.
10. Acute sprain, fracture of fissure, compression fracture, sacrococcygeal fracture, etc. (low frequency 100 Hz): 10-A to 10-F.
11. Improve the blood vessel tension and promote the blood circulation (the low frequency is 1Hz to 20 Hz): 11-A to 11-F.
12. The muscles losing the nerves contract (the low frequency is 1 Hz-2 Hz): 12-A to 12-F.
13. Exciting sympathetic nerves and promoting metabolism (low frequency 4 Hz-10 Hz): 13-A to 13-F.
14. Exciting sympathetic nerves and promoting metabolism (low frequency 4 Hz-10 Hz): 14-A to 14-F.
15. Exciting sympathetic nerves and promoting metabolism (low frequency 4 Hz-10 Hz): 15-A to 15-F.
This embodiment still discloses a medium frequency pulse therapeutic instrument controlling means, includes:
the analysis module is used for responding to the user setting instruction and analyzing the prescription parameters set by the user to obtain an analysis result;
the calculating module is used for calculating waveform parameters based on the analysis result;
the parameter judging module is used for judging whether the parameters meet the set requirements or not based on the obtained waveform parameters;
the time judging module is used for judging whether the set treatment time is reached or not if the set treatment time is met;
the prescription judging module is used for judging whether all prescriptions set by the user are executed when the set treatment time is reached;
and the ending module is used for ending if the prescription set by the user is completely executed.
Optionally, the prescription parameters set by the user include treatment channels, prescription number and prescription.
Optionally, the parsing result includes:
a mid-frequency, a prescription waveform, a low-frequency, and a low-frequency amplitude modulation.
Optionally, the calculating the waveform parameter includes:
generating random parameters based on the analysis result;
checking the random parameter;
and carrying out superposition secondary modulation on the random parameters passing the verification to obtain waveform parameters.
The intermediate frequency pulse therapeutic instrument disclosed by the embodiment comprises an intermediate frequency pulse circuit.
Intermediate frequency pulse circuit, including: the control circuit board is electrically connected with the pulse circuit board;
the control circuit board comprises a main control circuit, a serial port communication circuit, a first power supply circuit, an FPGA circuit, a digital-to-analog conversion circuit, a driving circuit and a first interface circuit;
as shown in fig. 2, the main control circuit includes a main control chip and a level shift chip, and in fig. 2, both the chip U2 and the chip U3 are level shift chips. As shown in fig. 3, the serial port communication circuit is electrically connected to the main control chip, as shown in fig. 4, the FPGA circuit is electrically connected to the level conversion chip, the FPGA circuit is electrically connected to the digital-to-analog conversion circuit, the driving circuit is electrically connected to the main control chip, the first interface circuit is electrically connected to the second interface circuit, and the first power supply circuit provides power to the control circuit board;
the pulse circuit board comprises a second interface circuit, a level conversion circuit, a board card address selection circuit, a communication circuit, a second power supply circuit, a waveform output circuit, an analog-to-digital conversion circuit, a single-channel waveform selection circuit, a power amplification circuit and a signal acquisition circuit;
the second interface circuit is connected with the level conversion circuit electricity, the second interface circuit is connected with integrated circuit board address selection circuit electricity, communication circuit is connected with integrated circuit board address selection circuit, waveform selection circuit and power amplifier circuit electricity respectively, analog-to-digital conversion circuit is connected with signal acquisition circuit, level conversion circuit and integrated circuit board address selection circuit electricity respectively, power amplifier circuit is connected with signal acquisition circuit, communication circuit and level conversion circuit electricity respectively, single channel waveform selection circuit is connected with power amplifier circuit, communication circuit and signal acquisition circuit electricity respectively, waveform output circuit is connected with second interface circuit and single channel waveform selection circuit electricity respectively, second power supply circuit provides the power for the pulse circuit board.
The second interface circuit is used for the communication between the pulse circuit board and the main control circuit, acquiring the command of the main control circuit and feeding back the voltage and current state to the main control circuit; the level conversion circuit converts TTL5v logic voltage into TTL3.3v logic voltage in the communication process, and a communication interface is protected; the board card address selection circuit is used for confirming a specified channel of a current command; the waveform selection circuit can meet the selection of each channel for the waveform; the power amplifying circuit is used for amplifying the selected waveform to meet the power requirement of treatment; the analog-to-digital conversion circuit is used for digitizing the voltage and current values of each channel waveform so as to send the digitized voltage and current values to the master control circuit through the second interface circuit.
Optionally, as shown in fig. 5, the digital-to-analog conversion circuit includes a digital-to-analog conversion chip U7 and a first operational amplifier, a resistor R6 is connected in series between the digital-to-analog conversion chip and a non-inverting input terminal of the first operational amplifier, a capacitor C18 is connected in series between the non-inverting input terminal of the first operational amplifier and ground, an output terminal of the first operational amplifier is connected in series with an inverting input terminal of the first operational amplifier, and an output terminal of the first operational amplifier is connected in series with the resistor R7.
Optionally, as shown in fig. 6, the first power supply circuit includes a 5V power supply circuit, the 5V power supply circuit includes a voltage-reducing conversion chip, a capacitor C25 is connected in series between a VIN pin of the voltage-reducing conversion chip and a GND pin of the voltage-reducing conversion chip, a capacitor C26 is connected in parallel with the capacitor C25, a series circuit formed by a resistor R14 and a resistor R17 is connected in parallel with the capacitor C26, a node between the resistor R14 and the resistor R17 is connected to an EN pin of the voltage-reducing conversion chip, a resistor R16 and a capacitor C29 are connected in series between a COMP pin of the voltage-reducing conversion chip and the GND pin of the voltage-reducing conversion chip, a capacitor C27 is connected in parallel with the capacitor C29, a capacitor C28 is connected in series between an SS pin of the voltage-reducing conversion chip and a GND pin of the voltage-reducing conversion chip, a capacitor C22, an inductor L1 and a capacitor C23 are connected in series between a BOOT pin of the voltage-reducing conversion chip and ground, a capacitor C24 is connected in parallel with a capacitor C23, a series circuit formed by a resistor R15 and a resistor R18 is connected in parallel with a node of the voltage-reducing conversion chip, a voltage-regulating diode is connected in series between a PH pin of the voltage-regulating chip and ground, and a vsr 18 are connected to a node of the voltage-regulating chip.
The first power supply circuit further includes a reference power supply circuit and a 3.3V power supply circuit, wherein the reference power supply circuit is shown in fig. 7, and the 3.3V power supply circuit is shown in fig. 8.
Optionally, as shown in fig. 9, the first interface circuit includes a gold finger interface, a resistor R23, a resistor R24, and a driving chip U15E are connected in series between the gold finger interface and the main control chip, a node between the resistor R23 and the resistor R24 is connected to an anode of the diode D2, a cathode of the diode D2 is connected to one end of the driving chip U14E, the other end of the driving chip U14E is connected to the main control chip, and the resistor R22 is connected to the diode D2 in parallel.
Fig. 10 is an electronic circuit diagram of the driving circuit, and the driving circuit is connected to the main control chip.
As shown in fig. 11, it is an electronic circuit diagram of the second interface circuit, and the second interface circuit is connected to the first interface circuit and is used for receiving signals of the control circuit board.
As shown in fig. 12, the level shift circuit is a bus switch for level shifting.
Optionally, as shown in fig. 14, the board card address selection circuit includes a logic gate chip U405 and a logic gate chip U406, the logic gate chip U405 is connected to the logic gate chip U406, a light emitting diode and a resistor R425 are connected in series between an output pin of the logic gate chip U406 and a power supply, an anode of the light emitting diode is connected to the resistor R425, and a resistor R426 is connected in series between a 1D input terminal of the logic gate chip U406 and ground.
Optionally, as shown in fig. 13, the communication circuit includes a serial-to-parallel chip and a decoder, where the two serial-to-parallel chips are a chip U404 and a chip U407, respectively, and the chip U402 is a decoder. The serial-to-parallel chip is connected with the decoder, a triode Q2 is connected between a QD pin of the serial-to-parallel chip and the ground in series, a base electrode of the triode Q2 is connected with the QD pin of the serial-to-parallel chip, an emitting electrode of the triode Q2 is connected with the ground, a collecting electrode of the triode Q2 is connected with a collecting electrode of the triode Q3, the emitting electrode of the triode Q3 is connected with the ground, and a base electrode of the triode Q3 is connected with a QC pin of the serial-to-parallel chip.
Optionally, as shown IN fig. 19, the signal collecting circuit includes a current detecting chip and a second operational amplifier, an IN + pin of the current detecting chip is connected to the transformer coil, a TVS diode is connected between output ends of the transformer coil, a series circuit formed by a resistor R148 and a capacitor C133 is connected IN parallel with the TVS diode, a capacitor C149 is connected IN parallel with the TVS diode, a resistor R150 and a capacitor C140 are connected IN series between an OUT pin of the current detecting chip and ground, a zener diode D102 is connected IN parallel with the capacitor C140, an anode of the zener diode D102 is connected to ground, one input end of the transformer coil is connected to the IN + pin of the current detecting chip, another input end of the transformer coil is connected to a non-inverting input end of the second operational amplifier by a resistor R145, an inductor L100 is connected IN series between the other input end of the transformer coil and the power amplifying circuit, an inductor L101 is connected IN series between an IN-pin of the current detection chip and the power amplifying circuit, a resistor R147 is connected IN series between the IN-pin of the current detection chip and an inverting input end of the second operational amplifier, a resistor R146 is connected IN series between the inverting input end and an output end of the second operational amplifier, a resistor R141 and a resistor R144 are connected IN series between a non-inverting input end of the second operational amplifier and the ground, a resistor R141 and a resistor R142 are connected IN series between the non-inverting input end of the second operational amplifier and the 5V power supply, a capacitor C131 is connected IN series between the 5V power supply and the ground, a resistor R143 and a capacitor C132 are connected IN series between the output end of the second operational amplifier and the ground, a voltage stabilizing diode D100 is connected IN parallel with the capacitor C132, and the anode of the voltage stabilizing diode D100 is grounded.
Optionally, as shown in fig. 16, the single-channel waveform selection circuit includes an analog switch, a digital potentiometer and a third operational amplifier, the chip U101 is the analog switch, and the chip U102 is the digital potentiometer. A capacitor C101 and a resistor R104 are connected in series between the COM pin of the analog switch and the inverting input end of the third operational amplifier, a resistor R105 is connected in series between a node between the capacitor C101 and the resistor R104 and the ground, a resistor R102 and a resistor R106 are connected in series between the non-inverting input end of the third operational amplifier and the ground, a resistor R102 and a resistor R100 are connected in series between the non-inverting input end of the third operational amplifier and the 5V power supply, the POA pin of the digital potentiometer is connected with the inverting input end of the third operational amplifier, a resistor R107 is connected in series between the POB pin of the digital potentiometer and the output end of the third operational amplifier, and a resistor R103 and a capacitor C102 are connected in series between the output end of the third operational amplifier and the ground.
As shown in fig. 17, the output end of the power amplifying circuit is connected to the input end of the signal collecting circuit.
Optionally, as shown in fig. 15, the waveform output circuit includes a fourth operational amplifier, a resistor R414 is connected in series between a non-inverting input terminal of the fourth operational amplifier and the second interface circuit, an inverting input terminal of the fourth operational amplifier is connected to an output terminal of the fourth operational amplifier, and an output terminal of the fourth operational amplifier is connected to the single-channel waveform selection circuit.
The analog-to-digital conversion circuit is shown in fig. 18 and is used for converting the analog signal of the signal acquisition circuit into a digital signal.
The foregoing describes the general principles of the present disclosure in conjunction with specific embodiments, however, it is noted that the advantages, effects, etc. mentioned in the present disclosure are merely examples and are not limiting, and they should not be considered essential to the various embodiments of the present disclosure. Furthermore, the foregoing disclosure of specific details is for the purpose of illustration and description and is not intended to be limiting, since the disclosure will be described in detail with reference to specific details.
The foregoing description has been presented for purposes of illustration and description. Furthermore, this description is not intended to limit embodiments of the disclosure to the form disclosed herein. While a number of example aspects and embodiments have been discussed above, those of skill in the art will recognize certain variations, modifications, alterations, additions and sub-combinations thereof.
Claims (10)
1. A control method of an intermediate frequency pulse therapeutic apparatus is characterized by comprising the following steps:
responding to a user setting instruction, analyzing prescription parameters set by the user to obtain an analysis result;
calculating waveform parameters based on the analysis result;
judging whether the parameters meet the set requirements or not based on the obtained waveform parameters;
if the treatment time is in accordance with the set requirement, judging whether the set treatment time is reached;
when the set treatment time is up, judging whether all prescriptions set by the user are executed;
if the user sets that the prescription is completely executed, the method is ended.
2. The method of claim 1, wherein the prescription parameters set by the user include treatment channel, prescription number and prescription.
3. The method of claim 1, wherein the analyzing the result comprises:
a mid-frequency, a prescription waveform, a low-frequency, and a low-frequency amplitude modulation.
4. The method of claim 1, wherein the calculating the waveform parameters comprises:
generating random parameters based on the analysis result;
checking the random parameter;
and carrying out superposition secondary modulation on the random parameters passing the verification to obtain waveform parameters.
5. The method for controlling an intermediate frequency impulse therapy apparatus according to claim 1, further comprising the step of determining whether the set treatment time is reached, after the step of:
if the set treatment time is not reached, judging whether to replace the waveform parameters;
if the waveform parameters need to be updated, the waveform parameters are calculated from the new waveform parameters.
6. An intermediate frequency impulse therapy instrument control device, comprising:
the analysis module is used for responding to a user setting instruction and analyzing the prescription parameters set by the user to obtain an analysis result;
the calculation module is used for calculating the waveform parameters based on the analysis result;
the parameter judging module is used for judging whether the parameters meet the set requirements or not based on the obtained waveform parameters;
the time judging module is used for judging whether the set treatment time is reached or not if the set treatment time is met;
the prescription judging module is used for judging whether all prescriptions set by the user are executed when the set treatment time is reached;
and the ending module is used for ending if the prescription set by the user is completely executed.
7. The if pulse therapy machine control of claim 6, wherein the user-set prescription parameters include treatment channel, prescription quantity, and prescription.
8. The if pulse therapy machine control apparatus of claim 6, wherein said parsing the results comprises:
medium frequency, prescription waveform, low frequency, and low frequency amplitude.
9. The midrange pulse therapy machine control apparatus according to claim 6, wherein said calculating waveform parameters comprises:
generating random parameters based on the analysis result;
checking the random parameter;
and carrying out superposition secondary modulation on the random parameters passing the verification to obtain waveform parameters.
10. An intermediate frequency pulse therapeutic apparatus, characterized by comprising: the control method according to any one of claims 1 to 5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310001082.0A CN115671551B (en) | 2023-01-03 | 2023-01-03 | Control method and device for intermediate frequency pulse therapeutic apparatus and therapeutic apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310001082.0A CN115671551B (en) | 2023-01-03 | 2023-01-03 | Control method and device for intermediate frequency pulse therapeutic apparatus and therapeutic apparatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115671551A true CN115671551A (en) | 2023-02-03 |
| CN115671551B CN115671551B (en) | 2023-04-07 |
Family
ID=85057016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310001082.0A Active CN115671551B (en) | 2023-01-03 | 2023-01-03 | Control method and device for intermediate frequency pulse therapeutic apparatus and therapeutic apparatus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115671551B (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN85107310A (en) * | 1985-10-08 | 1986-07-23 | 中国人民解放军空军总医院 | Computer mid-frequency electrotherapy device |
| CN1037458A (en) * | 1988-05-10 | 1989-11-29 | 中国人民解放军空军总医院 | The microcomputer mid-frequency treatment device |
| CA1315345C (en) * | 1986-07-29 | 1993-03-30 | Zion Educational Foundation | Method and apparatus for delivering a prescriptive electrical signal |
| CN2912678Y (en) * | 2005-11-29 | 2007-06-20 | 中国矿业大学 | Portable intelligent electrotherapy equipment |
| CN102186538A (en) * | 2008-08-25 | 2011-09-14 | 应用磁学有限责任公司 | Systems and methods for providing a magnetic resonance treatment to a subject |
| CN102813998A (en) * | 2012-08-01 | 2012-12-12 | 上海交通大学 | Multifunctional composite rehabilitation system for patient suffering from central nerve injury |
| CN110215603A (en) * | 2019-07-05 | 2019-09-10 | 金娜 | A kind of production method and device, physiotherapy equipment of physiotherapy equipment electric pulse |
| CN114367037A (en) * | 2021-12-23 | 2022-04-19 | 深圳市乐卿保健器械有限责任公司 | Pulse output control method and device, therapeutic instrument and storage medium |
| US20220189609A1 (en) * | 2019-03-29 | 2022-06-16 | Resmed Inc. | Storing, controlling, and porting respiratory settings from a remote server |
-
2023
- 2023-01-03 CN CN202310001082.0A patent/CN115671551B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN85107310A (en) * | 1985-10-08 | 1986-07-23 | 中国人民解放军空军总医院 | Computer mid-frequency electrotherapy device |
| CA1315345C (en) * | 1986-07-29 | 1993-03-30 | Zion Educational Foundation | Method and apparatus for delivering a prescriptive electrical signal |
| CN1037458A (en) * | 1988-05-10 | 1989-11-29 | 中国人民解放军空军总医院 | The microcomputer mid-frequency treatment device |
| CN2912678Y (en) * | 2005-11-29 | 2007-06-20 | 中国矿业大学 | Portable intelligent electrotherapy equipment |
| CN102186538A (en) * | 2008-08-25 | 2011-09-14 | 应用磁学有限责任公司 | Systems and methods for providing a magnetic resonance treatment to a subject |
| CN102813998A (en) * | 2012-08-01 | 2012-12-12 | 上海交通大学 | Multifunctional composite rehabilitation system for patient suffering from central nerve injury |
| US20220189609A1 (en) * | 2019-03-29 | 2022-06-16 | Resmed Inc. | Storing, controlling, and porting respiratory settings from a remote server |
| CN110215603A (en) * | 2019-07-05 | 2019-09-10 | 金娜 | A kind of production method and device, physiotherapy equipment of physiotherapy equipment electric pulse |
| CN114367037A (en) * | 2021-12-23 | 2022-04-19 | 深圳市乐卿保健器械有限责任公司 | Pulse output control method and device, therapeutic instrument and storage medium |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115671551B (en) | 2023-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9302102B2 (en) | Electro-therapeutic stimulator | |
| US20170071823A1 (en) | Electrotherapy system for traditional chinese medicine | |
| JP2002113115A (en) | Electrotherapeutical device utilizing variant system | |
| CN205055200U (en) | Facial paralysis electricity needle therapeutic instrument | |
| CN107158564A (en) | A kind of external diaphragm pacemaker of the medium frequency electric stimulation of low frequency modulations | |
| CN101827628B (en) | Apparatus and method for quick pain suppression | |
| CN115671551B (en) | Control method and device for intermediate frequency pulse therapeutic apparatus and therapeutic apparatus | |
| US3056409A (en) | Method of and means for physiotherapy | |
| CN1562404A (en) | Acupuncture first-aid therapeutic apparatus of cardio-pulmponary-cerebral resuscitation | |
| CN115765689A (en) | Intermediate frequency pulse circuit and therapeutic instrument | |
| CN1030134C (en) | Traditional Chinese medicine integral treatment instrument with electric pulse | |
| CN107050644A (en) | A kind of sacral nerve stimulation device of frequency of stimulation change | |
| CN207640809U (en) | A kind of pulse generating circuit through cranial nerve physical therapy apparatus | |
| TWI611369B (en) | Electric stimulation therapy expert system and method for use of the same | |
| KR200276503Y1 (en) | Apparatus for controlling blood pressure | |
| US9808621B2 (en) | System and method for reversing the effects of paralysis | |
| WO2004011087A1 (en) | System designed to generate programmed sequences of stimuli resulting in controlled and persistent physiological responses in the body | |
| CN1676174A (en) | Computerized medium frequency therapeutic equipment | |
| CN2688309Y (en) | Computer medium-frequency therapeutical equipments | |
| KR20190051402A (en) | A low frequency treatment device | |
| CN211188786U (en) | Gastrointestinal therapeutic apparatus | |
| RU2156144C2 (en) | Device for applying physiotherapy with biofeedback | |
| TWM532061U (en) | Electrical stimulated curing expert system | |
| KR20090011455A (en) | Bio-energy activation mashine using subtle energy stimulus | |
| EP4225429A1 (en) | Stimulation pattern encoding and transfer protocol for tens and nmes devices |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |